VisionWave Holdings Announces Filing of Schedule 13G by Goldman Sachs Reporting Beneficial Ownership of Approximately 5.2% GlobeNewswire November 12, 2025 WEST HOLLYWOOD, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) — VisionWave Holding,s Inc. (Nasdaq: VWAV) today announced that The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed a Schedule 13G with the […]
Plymouth Rock and North Jersey Chamber of Commerce Launch New Insurance Discount Program New program further enhances Plymouth Rock's line-up of affinity affiliations GlobeNewswire November 12, 2025 WOODBRIDGE, N.J., Nov. 12, 2025 (GLOBE NEWSWIRE) — Plymouth Rock Assurance, a leading auto and home insurance provider in the Northeast, is proud to announce a new insurance
Microirrigation Systems Market on the Rise: Smarter Farming, Bigger Growth | Asia Pacific Leads the Charge in Microirrigation Adoption GlobeNewswire November 12, 2025 Delray Beach, FL , Nov. 12, 2025 (GLOBE NEWSWIRE) — According to a research report published by MarketsandMarkets, The global microirrigation systems market is on a high-growth trajectory. Valued at USD 10.4
Radiopharm Theranostics starts enrollment of the Third Cohort of Phase 1 Dose Escalation Clinical Trial of 177Lu-RAD204 GlobeNewswire November 12, 2025 Data Safety Monitoring Committee approves advancing to a higher dose of 90mCi The first two Cohorts' patients show tumor uptake and a favourable safety profile SYDNEY, Nov. 12, 2025 (GLOBE NEWSWIRE) — Radiopharm Theranostics
Profound Medical Announces Strategic Distribution Agreement with Getz Healthcare to Bring TULSA-PRO(R) to Australia and New Zealand GlobeNewswire November 12, 2025 TORONTO, Nov. 12, 2025 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased
IO Biotech Announces Participation in Upcoming Investor Conferences GlobeNewswire November 12, 2025 NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced that members of its senior management team will participate in the following upcoming investor conferences: Event: Jefferies Global
Rocky Mountain Chocolate Factory Celebrates Grand Opening of New Charleston Prototype Store GlobeNewswire November 12, 2025 DURANGO, Colo., Nov. 12, 2025 (GLOBE NEWSWIRE) — Rocky Mountain Chocolate Factory is thrilled to announce the grand opening of its entirely new prototype store on King Street, taking place the weekend of November 13-15. This marks the debut
Indaptus Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update GlobeNewswire November 12, 2025 NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) — Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, today announces financial results for the third quarter
Peer To Peer Network Installs New AI Product Suite on Company Site for Live Testing GlobeNewswire November 12, 2025 CAMBRIDGE, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) — Peer To Peer Network, Inc. (OTC: PTOP) is pleased to announce that its new AI division, Intelligence Labs, has successfully integrated several components of its new AI product
Amaze Completes Acquisition of The Food Channel With Plans to Revamp Platform Experience for Culinary Creators The stock-based purchase strengthens Amaze's position in the growing food and beverage creator economy GlobeNewswire November 12, 2025 NEWPORT BEACH, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) — Amaze Holdings, Inc. (NYSE American: AMZE) (“Amaze”) a global leader in creator-powered